What is Eikon Therapeutics, Inc. 's EPS (basic)?

Eikon Therapeutics, Inc. (EIKN) reported EPS (basic) of -$2.46 in Q1 2026.

What does EPS (basic) mean?

Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.

Eikon Therapeutics, Inc. EIKN EPS (Basic)

EPS (Basic) at other companies

MYR GroupMYRG

$3.01+106%

Dave, Inc.DAVE

$4.31+96.8%

Cabot CorporationCBT

$1.27-25.7%

Travel + LeisureTNL

$1.25+14.7%

Warrior Met CoalHCC

$1.37+956%

Main Street CapitalMAIN

$0.93-4.1%

Other financials

Income statement

See full

Operating income-$87.3M-22.3%

Net income-$83.0M-21.6%

EPS (diluted)-$2.46+90.9%

Balance sheet

See full

Cash & equivalents$161.2M-21.2%

Total debt$254.8M—

Total equity$550.7M+186%

Total assets$850.8M—

Cash flow

See full

Operating cash flow-$89.8M-64.7%

CapEx$262.0K-98.8%

Free cash flow-$90.1M-17.1%

Valuation

See full

Market cap$521.35M—

Where this comes from

Reported directly by Eikon Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.

The official record: Eikon Therapeutics, Inc. ’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eikon Therapeutics, Inc. 's eps (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Eikon Therapeutics, Inc. 's EPS (basic)?: Eikon Therapeutics, Inc. (EIKN) reported EPS (basic) of -$2.46 in Q1 2026.
What does EPS (basic) mean?: Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.